DeepMed Research

ROXALL Medicina España S.A.

Country

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Study to Evaluate the Safety of Treatment With A"LLERGOVAC® HIMENÓPTEROS" in Patients Sensitized to This Venom

Conditions: Allergy to Himenoptera Venom

First Posted Date: 2019-10-02

Last Posted Date: 2022-03-17

Lead Sponsor: Roxall Medicina España S.A

Target Recruit Count: 50

Registration Number: NCT04112797

Locations: 🇪🇸
C.H.U. A Coruña, A Coruña, Spain
🇪🇸
Hospital Fundación Alcorcón, Madrid, Spain
🇪🇸
Hospital Santa Maria, Lleida, Spain

and more 5 locations

Study to Evaluate the Efficacy and Safety of "Allergovac Poliplus" in Polysensitized Patients With Allergic Rhinitis/Rhinoconjunctivitis, With or Without Asthma

Completed

Conditions: Rhinitis, Allergic
Rhinoconjunctivitis

First Posted Date: 2019-01-29

Last Posted Date: 2021-10-20

Lead Sponsor: Roxall Medicina España S.A

Target Recruit Count: 122

Registration Number: NCT03821077

Locations: 🇪🇸
Allercen, Barcelona, Spain
🇪🇸
Centre Assistencial Baix Llobregat, Cornellà De Llobregat, Barcelona, Spain
🇪🇸
Hospital de Igualada, Igualada, Barcelona, Spain

and more 7 locations

Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Allergic Rhinoconjunctivitis Sensitized to House Dust Mites

Phase 1

Completed

Conditions: Allergic Rhinoconjunctivitis

First Posted Date: 2016-08-29

Last Posted Date: 2017-10-20

Lead Sponsor: Roxall Medicina España S.A

Target Recruit Count: 43

Registration Number: NCT02881879

Locations: 🇪🇸
Hospital Germans Triasl i Pujol, Badalona, Barcelona, Spain
🇪🇸
Hospital de Basurto, Bilbao, Spain
🇪🇸
Hospital de Valdecilla, Santander, Spain

and more 2 locations

A Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea

Phase 1

Completed

Conditions: Rhinoconjunctivitis

Interventions: Biological: Allergovac depot with Olea europaea pollen extract

First Posted Date: 2016-07-29

Last Posted Date: 2017-10-23

Lead Sponsor: Roxall Medicina España S.A

Target Recruit Count: 47

Registration Number: NCT02849210

Locations: 🇪🇸
Hospital Santa Bárbara, Puertollano, Ciudad Real, Spain
🇪🇸
Complejo Hospitalario de Jaén, Jaén, Andalucía, Spain
🇪🇸
Hospital Infanta Cristina, Badajoz, Spain

and more 2 locations

A Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Olea Europaea and Phleum Pratense

Phase 1

Completed

Conditions: Rhinoconjuntivitis

Interventions: Biological: allergovac polimerized (100/100)

First Posted Date: 2016-07-29

Last Posted Date: 2017-05-01

Lead Sponsor: Roxall Medicina España S.A

Target Recruit Count: 52

Registration Number: NCT02849249

Locations: 🇪🇸
Hospital de Zafra, Zafra, Badajoz, Spain
🇪🇸
Hospital de Henares, Henares, Madrid, Spain
🇪🇸
Hospital Universitario Virgen del Rocío, Sevilla, Spain

and more 2 locations

Evaluation of Tolerability and Safety of "Allergovac Poliplus" in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice

Completed

Conditions: Asthma
Allergic Rhinitis
Rhinoconjunctivitis

Interventions: Biological: Allergovac Poliplus

First Posted Date: 2016-07-26

Last Posted Date: 2019-01-25

Lead Sponsor: Roxall Medicina España S.A

Target Recruit Count: 152

Registration Number: NCT02844842

Locations: 🇪🇸
C.H.U A Coruña, A Coruna, Spain
🇪🇸
Clínica Dr. Arias Irigoyen, Huelva, Spain
🇪🇸
Clínica Dra. Victoria Moreno, Huelva, Spain

and more 12 locations

Study for Evaluating Life Quality in Patients With Rhinoconjunctivitis

Completed

Conditions: Allergic Rhinoconjunctivitis

First Posted Date: 2015-07-02

Last Posted Date: 2017-10-20

Lead Sponsor: Roxall Medicina España S.A

Target Recruit Count: 215

Registration Number: NCT02488447

Locations: 🇪🇸
Complejp Hospitalario de Cáceres, Cáceres, Extremadura, Spain
🇪🇸
Complejo Hospitalario Universitario La Coruña, La Coruña, Galicia, Spain
🇪🇸
Hospital Central de la Cruz Roja, Madrid, Spain

and more 11 locations

A Multicenter, Open Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Parietaria Judaica

Phase 1

Completed

Conditions: Rhinoconjunctivitis

Interventions: Biological: Allergovac depot with Parietaria judaica pollen extract

First Posted Date: 2015-06-23

Last Posted Date: 2017-05-01

Lead Sponsor: Roxall Medicina España S.A

Target Recruit Count: 51

Registration Number: NCT02477917

Locations: 🇪🇸
Hospital Vega Baja, Orihuela, Alicante, Spain
🇪🇸
Hospital de Manises, Manises, Valencia, Spain
🇪🇸
Hosptal de Sagunto, Sagunto, Valencia, Spain

and more 1 locations

Determination of Biological Activity of Three Allergen Extracts

Phase 2

Completed

Conditions: Hypersensitivity

Interventions: Biological: Skin Prick Test - Atopic subjects
Biological: Skin Prick Test - Non Atopic subjects
Biological: Skin Prick Test - Allergic subjects

First Posted Date: 2015-06-18

Last Posted Date: 2017-05-01

Lead Sponsor: Roxall Medicina España S.A

Target Recruit Count: 176

Registration Number: NCT02474836

Locations: 🇪🇸
Hospital General de Asturias, Oviedo, Asturias, Spain
🇪🇸
Hospital de Vinalopó, Elche, Alicante, Spain
🇪🇸
Al-lergo centre, Barcelona, Cataluña, Spain

and more 6 locations

Phase II Trial With Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense

Phase 2

Completed

Conditions: Allergic Rhinoconjunctivitis

Interventions: Biological: Allergovac Depot
Biological: Placebo

First Posted Date: 2012-03-30

Last Posted Date: 2019-04-29

Lead Sponsor: Roxall Medicina España S.A

Target Recruit Count: 151

Registration Number: NCT01567306

Locations: 🇪🇸
Hospital Universitario La Paz, Madrid, Spain
🇪🇸
Hospital Universitario Gregorio Marañón, Madrid, Spain
🇪🇸
Hospital Universitario Puerta de Hierro, Madrid, Spain

and more 7 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy